intercst
7 Likes
Hooray 1234567890
d fb
An increasing number of CEOs and investors are talking about how popular weight-loss drugs might change the economy and business. Earlier this week, the CEO of the maker of Pringles and Cheez-Its said the company is studying their potential impact on dietary behaviors.
“Like everything that potentially impacts our business, we’ll look at it, study it and, if necessary, mitigate,” Steve Cahillane, the CEO of Kellanova, said in an interview.
I read that last paragraph to mean we should look for the addition of even more addictive additives in our highly processed foods. Or maybe we’ll get studies funded by Kraft-Heinz, Mondeleze, McDonald’s, and PepsiCo on the dangers of Ozempic.
1 Like
Anybody thinking about shorting EATZ (restaurant ETF)? Puts are also available.
DB2
No. But I think it’s a good idea!!
'38Packard
2 Likes
Irony and greed department: Kellogg’s probably paid a fortune to some investment banker to expedite the split of the company, jettisoning the slow growth breakfast cereals, so the CEO makes more loot faster by narrowing the focus of the rump company to the higher growth, probably higher margin, junkier products, just in time for that horse to come up lame.
Steve
2 Likes
Apparently it’s not just grocers whose bottom line is getting lean?
Kidney disease is the bread n butter for the dialysis industry.
{ a medical trial showed a Novo Nordisk (NOVOb.CO) drug can reduce the risk of kidney failure.}
The “drug” tested was semaglutide.
{The success highlights how these drugs, which mimic a natural hormone called GLP-1, may pummel the medical world and beyond, leaving companies grappling with unexpected reductions in earnings.}
{In a recent drug trial, Wegovy, an obesity remedy made by Denmark’s Novo Nordisk, reduced the incidence of serious cardiovascular events like strokes and heart attacks by 20% in overweight patients.}
ralph
1 Like
Why, it’s enough to make you wonder if these desperste medical device companies are at the root of media reports on “Ozempic Face” and whatnot. 
I’m sure stranger things have happened.
1 Like
I have no idea if the probabilities of Ozempic face are accurate but it certainly exists.
1 Like
The “chubby chops to saggy, baggy features” phenom exists because of successful dramatic weight loss caused by an energy deficit. Ozempic, willpower or finding diet that right. All work.
It is actually a more deadpan face than any sagging. People actually lose their jowls first they are thinner. You know someone by their responsiveness and that dies.
So, you’re saying it’s possibly a neurological phenomenon and not just loss of fat and muscle? Affecting the muscles of facial expression selectively? Very unlikely.
I have not read up on the matter.
adding
One of the issues
- lipodystrophy, which affects how the body accumulates and stores fat
Lipodystrophy is a very unnatural look. I am in Starbucks and another friend who has had major yo-yo dieting maybe…probably…But I am not going to pester him at all.
Also from Google…so thankfully there are sources that don’t automatically term the appearance of rapid weight loss by medications taken, else we might have “Chemo Face”, or by disease status, “AIDS Face” (well, there probably are folk who use those descriptions but are selective when and where they do…)
Lipodystrophy isn’t one of the issues, though. Even your links don’t link the condition to Ozempic usage.
My link did cite Lipodystrophy.
- increased signs of aging, such as more lines and wrinkles
- loss of fat, which can lead the skin to become loose and sag
- a hollowed-out appearance
- [lipodystrophy]*(Lipodystrophy: Types, pictures, causes, and treatment), which affects how the body accumulates and stores fat
As far as the Mayo Clinic wanted to drop the pejorative term “Ozempic Face” which is typical of medicine and should be respected. But the medical practice that is causing this look is very problematic.
People need Ozempic because they won’t naturally cut calories and have multiple co-morbidities. The patients facing this condition have the need to medicate.
1 Like
Indeed, the article’s author did use that term …but I think it would be a mistake for anyone to infer a link between any of the lipodystrophy syndromes and Ozempic usage just yet, no matter how similar the features might be. An easy mistake to make but not if you read every link/hyperlink contained in the articles.
For but one (for some extraordinary reason cited among “acquired” lipodystrophy syndromes by the article’s author) As someone who doesn’t know enough to be due an opinion on these serious syndromes but does understand the definition of acquired vs. congenital, these conditions don’t look tremendously “acquired” to me (posting because this is an interesting review … to me at least…on a topic I hadn’t visited in a long time and my own post is as good a way to bookmark it for re-reading as anywhere)…
1 Like
VeeEnn,
I have heard that with liposuction fat comes back but in the shoulders. Is that a form of lipodystrophy? I’d assume it is. I’d also risk assuming these conditions are more common with unnatural ways of reducing fat.
But you are right to hold off.
I also have a sensitivity to those with any of these conditions. There are fewer choices.
It is unrealistic to push people to reduce calories more naturally.
1 Like
I don’t quite understand the WalMart thing. Does the average WalMart customer overlap much with the average Ozempic user (for weight loss)? Isn’t Ozempic still quite expensive for weight loss usage? And isn’t WalMart the “low price leader”?
I wonder if Whole Foods is seeing a decline in food purchases?
Offhand, I would say the Walmart clientele would be more likely to drop a pill, than change their lifestyle, while the Whole Foods clientele would be more likely to “eat right and exercise regularly”.
Steve
2 Likes
The wife of one of my nephews is on the Walmart spectrum and is currently using the Oz drug. She has another 50 pounds to lose before her doctor will do some necessary knee surgery.
DB2
1 Like